This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Latest comment: 7 years ago1 comment1 person in discussion
Prescribing Barriers in Psoriasis says "Concerns about increased risks of suicidal ideation and behavior in phase III studies were so great that the FDA approved brodalumab with a boxed warning and instituted a Risk Evaluation and Mitigation Strategy (REMS) program that raises barriers to prescribing the drug." The REMS is not yet defined so presumably Siliq is not yet available for use/sale/prescription. What should we say ? - Rod57 (talk) 12:58, 24 July 2017 (UTC)Reply